# Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)

> **NCT02691247** · PHASE2 · COMPLETED · sponsor: **Lisata Therapeutics, Inc.** · enrollment: 113 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** CLBS03 Low Dose
- **BIOLOGICAL:** CLBS03 High Dose
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02691247
- **Lead sponsor:** Lisata Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02
- **Primary completion:** 2019-03
- **Final completion:** 2020-01
- **Target enrollment:** 113 (ACTUAL)
- **Last updated:** 2021-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02691247

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02691247, "Safety and Efficacy of CLBS03 in Adolescents With Recent Onset Type 1 Diabetes (The Sanford Project T-Rex Study)". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT02691247. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*